Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Novartis AG (NVS) had Return on Equity of 5.24% for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
$7.42B |
|
$8.48B |
|
$1.08B |
|
$6.34B |
|
$5.19B |
|
$2.23B |
|
$-169.00M |
|
$2.06B |
|
$2.06B |
|
$2.45B |
|
$2.45B |
|
$8.48B |
|
$2.45B |
|
$2.23B |
|
$3.86B |
|
2.08B |
|
2.09B |
|
$4.10 |
|
$4.06 |
|
| Balance Sheet Financials | |
$30.48B |
|
$9.51B |
|
$69.46B |
|
$99.94B |
|
$26.39B |
|
$18.44B |
|
$26.80B |
|
$53.20B |
|
$46.75B |
|
$-3.47B |
|
$46.75B |
|
2.04B |
|
| Cash Flow Statement Financials | |
$14.46B |
|
$5.60B |
|
$-14.28B |
|
$7.52B |
|
$13.39B |
|
$5.88B |
|
$865.00M |
|
$-7.25B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.16 |
|
-- |
|
-- |
|
0.28 |
|
0.53 |
|
85.41% |
|
30.05% |
|
30.05% |
|
-- |
|
27.77% |
|
114.22% |
|
$13.63B |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.18 |
|
0.99 |
|
91.32 |
|
|
Return on Equity |
5.24% |
-70.55% |
|
2.45% |
|
3.76% |
|
$22.87 |
|
$6.52 |
|
$6.91 |
|